Michael moved to Austria after high school to study Molecular Medicine at the Medical University of Innsbruck. While studying there, he created a platform for genome-wide CRISPR/Cas9-loss-of-function screens at the Institute for Developmental Immunology (Biocenter). In his PhD research, he used this technique to discover new regulators of miRNA biogenesis and their function. Fascinated by regulatory molecular mechanisms and the interaction between RNA molecules and proteins, he joined the Grosshans Lab in early 2023. Currently, he is researching how LIN-28 regulates its targets during C. elegans development, using methods like biochemistry, microscopy, and omics.
Grosshans Lab 